|
|
Vaccine Detail
|
Fluzone Quadrivalent - Southern Hemisphere Formulation |
| Vaccine Information |
- Vaccine Name: Fluzone Quadrivalent - Southern Hemisphere Formulation
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Product Name: Influenza Virus Vaccine
- Tradename: Fluzone Quadrivalent Southern Hemisphere
- Manufacturer: Sanofi Pasteur
- Type: Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA
- Host Species for Licensed Use: Human
- Preservative: Thimerosal
- Allergen: Eggs
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F), do not freeze.
- Approved Age for Licensed Use: 6 months and older.
- Description: Fluzone Quadrivalent Southern Hemisphere(Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs. The Fluzone Quadrivalent Southern Hemisphere process uses an additional concentration factor after the ultrafiltration step in order to obtain a higher hemagglutinin (HA) antigen concentration. (FDA: Fluzone Quadrivalent SH)
|
| Host Response |
|
|
| References |
FDA: Fluzone Quadrivalent SH: FDA: Fluzone Quadrivalent Southern Hemisphere formulation vaccine information [https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM513242.pdf]
|
|
